New modular analytics solution empowers commercial teams to
optimize strategies and improve patient outcomes
LONDON, Jan. 14,
2025 /PRNewswire/ --
Clarivate Plc (NYSE:CLVT), a leading global provider of
transformative intelligence, today announced the launch of DRG
Fusion, an innovative platform to support commercial analytics in
life sciences. Powered by integrated real-world data and built by
clinical and data science experts, Fusion provides biopharma and
medtech organizations with the tools to understand and act in
varied disease and competitive landscapes — eliminating the
complexities of raw data management.
Biopharma and medtech organizations face increasing challenges
in extracting insights from fragmented data sources while adapting
to competitive pressures and shifting market demands. Fusion
addresses these issues by delivering market data and analytics from
integrated medical and pharmacy claims and other real-world data
sources, empowering life science organizations to create a
healthier tomorrow. Its user-tested workflows and on-going data
refreshes empower teams to quickly identify gaps in product
positioning and uncover opportunities to enhance patient
acquisition and retention.
Fusion addresses the critical needs of biopharma and medtech
commercial, sales and marketing teams by offering modular data
analytics products aligned to functional team needs. Pre-built
modules provide users with configurable dashboards to support
patient journey analysis, commercial targeting, market access
optimization and patient segmentation.
Abeezer Tapia, Senior Vice
President & General Manager, Real-World Data, Life Sciences
& Healthcare, Clarivate, said: "Fusion is built to
harness real-world data in specific ways to help our customers
maximize their product value. Its four product workflows cater to
specific objectives—be it sizing and segmenting target patient
populations, identifying and mitigating leakage points across the
patient journey, deploying sales teams based on precise commercial
targeting, or designing value messages and assistance programs to
optimize access. With data mastered at the drug and device level,
Fusion provides the targeted market insights that are critical to
inform biopharma and medtech decision-making."
Henry Levy, President, Life
Sciences & Healthcare, Clarivate, added: "Fusion
demonstrates the robustness of life sciences data from Clarivate
and its wide-ranging commercial applications. Its scalable data
architecture is carefully designed to rapidly deliver insights
across patient diseases and sub-population cohorts. We are
committed to investing in innovative technologies that empower our
clients to address healthcare's most pressing challenges. With new
AI-driven and self-service features set to launch in Fusion in
2025, we remain focused on delivering user-centric solutions that
drive meaningful value and impact for our customers."
Fusion streamlines the data management and querying process for
life sciences organizations by simplifying complex data analysis
with ready-made, informative visuals and tables accelerating
commercial decisions.
To learn more about how this modular analytics platform can
help organizations optimize their product launch and growth
strategies while improving patient outcomes, visit
here.
About Clarivate Real-World Data
Clarivate offers a unique blend of products and expert
consultancy to support you at every stage of your journey with
real-world data (RWD). Our platform seamlessly integrates medical
and pharmacy claims, SDoH, mortality and registry data to deliver
valuable insights across the development lifecycle. With
cohort-specific data tailored to your needs, we provide precise
answers to key business questions. Our modular analytics platform,
designed by data scientists, epidemiologists, and former
clinicians, provides functional insights to enhance your commercial
strategy. We also offer expert support in data configuration,
advanced ML models, and the integration of disparate datasets to
ensure you have the tools and expertise to drive success. Offerings
include Clarivate Real-World Data Nucleus, Clarivate Real-World
Data Fusion Platform, Clarivate Real-World Data Consulting &
Insights and Clarivate Real-World Data Rare Disease
Franchise.
About Clarivate
Clarivate™ is a leading global
provider of transformative intelligence. We offer enriched data,
insights & analytics, workflow solutions and expert services in
the areas of Academia & Government, Intellectual Property and
Life Sciences & Healthcare. For more information, please
visit www.Clarivate.com.
Media Contact:
Catherine
Daniel
Director, External Communications, Life Sciences &
Healthcare
newsroom@Clarivate.com
Logo -
https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clarivate-launches-drg-fusion---a-new-life-sciences-analytics-product-powered-by-real-world-data-302349886.html
